Citigroup’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $811M | Buy |
2,096,863
+1,858,013
| +778% | +$689M | 0.27% | 70 |
|
|
2026
Q1 | $69.9M | Buy |
238,850
+22,122
| +10% | +$7.27M | 0.03% | 523 |
|
|
2025
Q4 | $76M | Sell |
216,728
-39,535
| -15% | -$13.4M | 0.03% | 470 |
|
|
2025
Q3 | $82.8M | Sell |
256,263
-12,289
| -5% | -$3.82M | 0.04% | 440 |
|
|
2025
Q2 | $104M | Sell |
268,552
-131,155
| -33% | -$52.8M | 0.05% | 335 |
|
|
2025
Q1 | $174M | Buy |
399,707
+177,160
| +80% | +$71.1M | 0.09% | 207 |
|
|
2024
Q4 | $82.1M | Sell |
222,547
-23,855
| -10% | -$9.98M | 0.05% | 344 |
|
|
2024
Q3 | $128M | Sell |
246,402
-34,427
| -12% | -$18.4M | 0.07% | 226 |
|
|
2024
Q2 | $152M | Buy |
280,829
+17,072
| +6% | +$9.02M | 0.1% | 187 |
|
|
2024
Q1 | $137M | Buy |
263,757
+7,918
| +3% | +$3.94M | 0.09% | 211 |
|
|
2023
Q4 | $121M | Buy |
255,839
+32,785
| +15% | +$15.2M | 0.09% | 211 |
|
|
2023
Q3 | $97.1M | Sell |
223,054
-21,893
| -9% | -$9.93M | 0.07% | 241 |
|
|
2023
Q2 | $109M | Sell |
244,947
-17,508
| -7% | -$8.08M | 0.07% | 214 |
|
|
2023
Q1 | $121M | Sell |
262,455
-10,305
| -4% | -$4.9M | 0.08% | 185 |
|
|
2022
Q4 | $140M | Buy |
272,760
+58,527
| +27% | +$29.7M | 0.11% | 166 |
|
|
2022
Q3 | $97.3M | Sell |
214,233
-20,253
| -9% | -$9.69M | 0.07% | 227 |
|
|
2022
Q2 | $113M | Sell |
234,486
-21,044
| -8% | -$10.4M | 0.08% | 194 |
|
|
2022
Q1 | $126M | Buy |
255,530
+33,110
| +15% | +$15.1M | 0.08% | 235 |
|
|
2021
Q4 | $103M | Sell |
222,420
-90,105
| -29% | -$37.9M | 0.06% | 315 |
|
|
2021
Q3 | $117M | Buy |
312,525
+75,937
| +32% | +$28.9M | 0.07% | 249 |
|
|
2021
Q2 | $90.3M | Sell |
236,588
-86,055
| -27% | -$32.9M | 0.05% | 328 |
|
|
2021
Q1 | $116M | Buy |
322,643
+31,698
| +11% | +$10.2M | 0.07% | 240 |
|
|
2020
Q4 | $93.4M | Sell |
290,945
-118,843
| -29% | -$36.5M | 0.06% | 299 |
|
|
2020
Q3 | $110M | Buy |
409,788
+82,071
| +25% | +$22.1M | 0.07% | 220 |
|
|
2020
Q2 | $86.2M | Buy |
327,717
+67,556
| +26% | +$18M | 0.07% | 254 |
|
|
2020
Q1 | $59.1M | Buy |
260,161
+42,726
| +20% | +$11.6M | 0.05% | 306 |
|
|
2019
Q4 | $65.7M | Sell |
217,435
-276,566
| -56% | -$76.1M | 0.05% | 384 |
|
|
2019
Q3 | $119M | Buy |
494,001
+55,396
| +13% | +$15.2M | 0.09% | 189 |
|
|
2019
Q2 | $124M | Buy |
438,605
+201,407
| +85% | +$55M | 0.1% | 185 |
|
|
2019
Q1 | $68.1M | Sell |
237,198
-44,393
| -16% | -$12.8M | 0.07% | 281 |
|
|
2018
Q4 | $74M | Sell |
281,591
-125,547
| -31% | -$34.5M | 0.07% | 262 |
|
|
2018
Q3 | $112M | Buy |
407,138
+158,814
| +64% | +$41.2M | 0.1% | 175 |
|
|
2018
Q2 | $59.1M | Sell |
248,324
-34,670
| -12% | -$8.03M | 0.05% | 307 |
|
|
2018
Q1 | $62.2M | Buy |
282,994
+146,201
| +107% | +$34.3M | 0.05% | 325 |
|
|
2017
Q4 | $30.8M | Sell |
136,793
-60,151
| -31% | -$12.8M | 0.02% | 626 |
|
|
2017
Q3 | $37.4M | Buy |
196,944
+50,365
| +34% | +$9.59M | 0.03% | 506 |
|
|
2017
Q2 | $27.6M | Sell |
146,579
-10,922
| -7% | -$1.96M | 0.02% | 615 |
|
|
2017
Q1 | $26M | Buy |
157,501
+5,970
| +4% | +$950K | 0.02% | 639 |
|
|
2016
Q4 | $21.8M | Buy |
151,531
+48,308
| +47% | +$6.47M | 0.02% | 727 |
|
|
2016
Q3 | $12.9M | Buy |
103,223
+14,416
| +16% | +$1.86M | 0.01% | 913 |
|
|
2016
Q2 | $11.7M | Buy |
88,807
+31,261
| +54% | +$4.28M | 0.01% | 945 |
|
|
2016
Q1 | $8M | Sell |
57,546
-30,720
| -35% | -$4.11M | 0.01% | 1164 |
|
|
2015
Q4 | $12.3M | Sell |
88,266
-11,301
| -11% | -$1.56M | 0.01% | 1009 |
|
|
2015
Q3 | $13.9M | Buy |
99,567
+19,095
| +24% | +$2.87M | 0.01% | 917 |
|
|
2015
Q2 | $13.2M | Buy |
80,472
+22,413
| +39% | +$3.58M | 0.01% | 1028 |
|
|
2015
Q1 | $8.96M | Buy |
58,059
+11,451
| +25% | +$1.63M | 0.01% | 1263 |
|
|
2014
Q4 | $5.86M | Sell |
46,608
-35,517
| -43% | -$4.39M | 0.01% | 1675 |
|
|
2014
Q3 | $9.82M | Sell |
82,125
-25,425
| -24% | -$2.92M | 0.01% | 1290 |
|
|
2014
Q2 | $11.6M | Sell |
107,550
-23,911
| -18% | -$2.46M | 0.01% | 1160 |
|
|
2014
Q1 | $13.1M | Sell |
131,461
-24,799
| -16% | -$2.24M | 0.01% | 975 |
|
|
2013
Q4 | $14.4M | Sell |
156,260
-40,629
| -21% | -$3.61M | 0.01% | 963 |
|
|
2013
Q3 | $16.5M | Buy |
196,889
+11,210
| +6% | +$961K | 0.02% | 839 |
|
|
2013
Q2 | $15.2M | Buy |
+185,679
| New | +$13.9M | 0.02% | 809 |
|
Other funds holding ELV
Citigroup's ELV Position: Q2 2026 in Review
Citigroup increased its Elevance Health (ELV) stake by 778% in Q2 2026, buying an estimated $689M and bringing the position to 2,096,863 shares worth $811M. The position accounts for 0.27% of the portfolio, ranked #70.
Citigroup first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Citigroup held 2,096,863 shares of Elevance Health worth $811M as of Q2 2026.
- Citigroup bought 1,858,013 Elevance Health shares in Q2 2026, an estimated $689M.
- Elevance Health made up 0.27% of Citigroup's portfolio in Q2 2026, its #70 holding.
- Citigroup first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.